CD79A and autoimmune polyendocrinopathy: The main difference between C-APS patients and controls was found in IgA aB2GPI antibodies positivity, combined with any other aPL (odds ratio 24.4 P < 0.0001) or isolated (odds ratio 17.4 P < 0.0001, Table 3).